Pharmacoeconomic analysis of perampanel for resistance partial epilepsy
Partial epilepsy is the most common type of seizures. Th e prevalence of partial epilepsy in Russia reached 325 thousand patients, with resistant to therapy about 276 thousand. Objective. Pharmacoeconomic analysis (PHe) was conducted for perampanel use in patients older than 14 years with resistance...
Main Authors: | D. Yu. Belousov, E. V. Afanasyeva, E. A. Efremova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Izdatelstvo OKI
2018-06-01
|
Series: | Качественная клиническая практика |
Subjects: | |
Online Access: | https://www.clinvest.ru/jour/article/view/194 |
Similar Items
-
Pharmacoeconomic analysis of adjuvant use of zonisamide therapy resistant partial epilepsy in adults
by: D. Yu. Belousov, et al.
Published: (2018-06-01) -
Pharmacoeconomic analysis of naft idrofuryl in patients with chronic obliterating diseases of lower limb arteries
by: A. E. Cheberda, et al.
Published: (2018-05-01) -
Pharmacoeconomic analysis of flexible-dose administration regimen of Xeomine® in patients with focal dystonia
by: A. E. Cheberda, et al.
Published: (2018-06-01) -
Результаты проведения фармакоэкономических анализов при лечении болезни Паркинсона агонистом дофаминовых рецепторов Мирапексом
Published: (2018-06-01) -
Pharmacoeconomic analysis of subdermal tocilizumab in patients with rheumatoid arthritis
by: S. K. Zyryanov, et al.
Published: (2018-05-01)